GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials. Επικοινωνία Submitted by Απόστολος Τσάπας on Τετ, 10/12/2022 - 09:12
